Global News Journal
Beyond the World news headlines
from Summit Notebook:
Swine flu sales: windfall or hard work?
Swine flu is turning out to be a sales bonanza for drug companies - just don't call it a windfall, says GlaxoSmithKline.
As one of the world's top suppliers of both vaccines and antiviral medicine, CEO Andrew Witty resents the implication that billions of dollars of business simply fell into his company's lap when the World Health Organisation declared H1N1 a pandemic in June.
"For me the word windfall means you're walking down the street and something fell out of the sky," he told the Reuters Health Summit. "We've spent the best part of 15 years investing for this situation and our ability to manufacture and supply potentially 500 million or so doses (of vaccine) is all because of these investments."
from Maggie Fox:
Where scientists go to learn about swine flu
Usually, at a forum on swine flu, all the experts stand up, present a bunch of general background material, a few new findings, and leave. The learning curve on H1N1 is so steep that by the time you fill in the background, you are out of time, and there's no point in hearing the next presenter speak to a general audience
But this week's Institute of Medicine meeting was different. Epidemiologists - the people who specialize in how disease spreads - were talking to molecular geneticists. Keiji Fukuda of the World Health Organization filled in the bench scientists on how negotiating to get vaccines and drugs for poor countries was taking up everyone's valuable time. Veterans of the 1976 swine flu vaccine mess told their stories. Every scientist sat there raptly listening to the other's presentations. Much of the material had not yet gone through the time consuming peer-review process needed for publication in a medical journal, so it was a little raw, but that much more useful and timely to an educated audience.
from Maggie Fox:
Is swine flu an investment opportunity?
You can prevent swine flu by washing your hands and keeping away from sick people, but how do you make money off of it? Some smaller companies such as Vical and Novavax hope the pandemic might make a short cut for them.
In general vaccines are not lucrative money-makers but this could change.
And then there are always the big antiviral makers. CDC's new guidelines do not offer hope for much more market for them, however. They recommend preserving these drugs for people who really need them.
Pigs might fly, but swine flu!
By David Fox
“I called the swine flu hotline, but all I got was crackling”.
The reference to “crackling”, or pork rinds, starts a host of Internet jokes and puns about the new H1N1 strain of flu that has the world on edge but fortunately, so far, has not reached the pandemic proportions feared originally.
The growth of the Internet – and more particularly social networking sites such as Facebook, Twitter and Friendster – means that information about health issues can spread even faster than the most virulent epidemic.
Tracking the flu with George Washington
Northwestern professor Dirk Brockmann thinks he can track the spread of H1N1 flu and other future epidemics, thanks in part to the humble $1 bill.
“We’re looking at how people travel in the United States and Europe and trying to find a theory behind human traffic,” Brockmann said. “Then we can unravel the structures within these networks and explain them.”
Everything you wanted to know about swine flu
John McConnell, an editor at The Lancet and founding Editor of The Lancet Infectious Diseases, is answering questions about the swine flu:
What is the science behind how new flu strains arise – this one has pig, human and bird components (mainly pig). How has it got this way and how is it able to gain each of these components?
